| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690684 | Gynecologic Oncology | 2016 | 8 Pages |
Abstract
Patients administered IP after IDS had a high rate of successful port utilization, with few regimen switches. Oncologic outcomes were optimal in patients with a CGR at IDS, regardless of chemotherapy used.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jennifer J. Mueller, Amelia Kelly, Qin Zhou, Alexia Iasonos, Kara Long Roche, Yukio Sonoda, Roisin E. O'Cearbhaill, Oliver Zivanovic, Dennis S. Chi, Ginger J. Gardner,